Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | RORC | P51449 | 6/20 | 0.36 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.35 |
| ▸ | RARG | P13631 | 3/20 | 0.35 |
| ▸ | PGR | P06401 | 2/20 | 0.34 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.34 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19890936 | 0.80 | L3MBTL1 (0.57) | KDM4EATML3MBTL1MAPK1PGR | |
| SCHEMBL31070189 | 0.80 | L3MBTL1 (0.61) | KDM4EATML3MBTL1MAPK1RORC | |
| SCHEMBL15987511 | 0.80 | L3MBTL1 (0.61) | KDM4EATML3MBTL1MAPK1RORC | |
| SCHEMBL14924653 | 0.80 | L3MBTL1 (0.50) | KDM4EATML3MBTL1MAPK1PGR | |
| SCHEMBL19046742 | 0.80 | L3MBTL1 (0.55) | KDM4EATML3MBTL1MAPK1PGR | |
| SCHEMBL23741295 | 0.79 | L3MBTL1 (0.59) | KDM4EATML3MBTL1MAPK1PGR | |
| SCHEMBL12249843 | 0.79 | L3MBTL1 (0.59) | KDM4EATML3MBTL1MAPK1PGR | |
| SCHEMBL20276611 | 0.79 | L3MBTL1 (0.48) | KDM4EATML3MBTL1MAPK1RORC | |
| SCHEMBL19573618 | 0.79 | L3MBTL1 (0.55) | KDM4EATML3MBTL1MAPK1PGR | |
| SCHEMBL17123099 | 0.79 | L3MBTL1 (0.64) | KDM4EATML3MBTL1MAPK1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220020932-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2022-01-20 | — | — | US | disclosed |
| WO-2020101169-A1 | COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC APPARATUS THEREOF | 덕산네오룩스 주식회사 | 2020-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220020932-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | PIEZO1, OR51E2, OR10J3 | KDM4E 636/4885ATM 4145/4885L3MBTL1 833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.